TuHURA Biosciences, Inc. (HURA)
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.
$2.17+0.06%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-9.6%
The outlook
TuHURA Biosciences, Inc. currently reads as leaning bullish based on mixed vs its moving averages, 50% of the way from its 52-week low to high, avg target +271% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range50% of the way from its 52-week low to high
Price targetAvg target +271% vs current price
Analyst price target
~12-month · 5 analysts$8.04average target+270.5% vs now
Now $2.17
Low $6.20High $10.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$138.2M
52-wk high
$3.90
52-wk low
$0.41
50-day avg
$2.30
200-day avg
$1.85
Trailing P/E
—